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Abstract
Background:  Liver  haemangiomas  are  the  most  common  benign  tumours,  commonly  presented
in women  and  considered  giant  when  their  diameter  surpasses  4  cm.  They  are  mostly  asymp-
tomatic  and  incidentally  found.  They  manifest  with  abdominal  pain  and  mass  effect.  These
tumours  can  be  managed  by  observation,  enucleation,  resection,  and  embolisation.
Objective:  To  determine  the  experience  in  our  unit  as  regards  the  treatment  and  post-surgical
outcomes  of  patients  with  liver  haemangiomas.
Materials  and  methods: A  retrospective  study  was  performed  on  14  patients  with  a  histopatho-
logical diagnosis  of  liver  haemangioma.  An  analysis  was  made  using  the  sociodemographic,
tumour-related  and  surgical  related  variables,  as  well  as  any  complications.
Results:  Of  the  14  patients  analyse,  there  were  7  males  and  7  females,  with  a  median  age  of
43.43 ±  15.03  years,  and  a  mean  tumour  size  of  6.86  ±  3.5  cm.  Eight  (51.7%)  of  the  tumours
were located  in  the  right  lobe,  3  (21.4%)  in  the  left  lobe,  and  3  (21.4%)  in  the  caudate  lobe.
Resection was  performed  in  7  patients  (50%),  enucleation  in  5  patients  (35.7%),  and  biopsy  in
2 patients  (14.3).  No  relationship  was  found  between  sex,  pathology,  or  tumour  location.  No
morbidity  or  mortality  was  found.
Conclusions:  Liver  haemangiomas  in  our  unit  have  similar  characteristics  to  those  described  in
other studies.  Surgical  treatment  in  our  hospital  offers  a  positive  outcome.
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Tratamiento  quirúrgico  de  los  hemangiomas  hepáticos  en  una  unidad  médica  de  alta
especialidad  del  sureste  de  México
Resumen
Antecedentes:  Los  hemangiomas  hepáticos  son  los  tumores  hepáticos  benignos  más  comunes,
predominan  en  las  mujeres  y  se  consideran  gigantes  los  mayores  de  4  cm.  Son  asintomáticos  y
generalmente  su  hallazgo  es  incidental.  Sus  síntomas  pueden  ser:  dolor  abdominal  y  efecto  de
masa. Los  hemangiomas  se  pueden  observar,  enuclear,  resecar  o  embolizar.
Objetivo:  Determinar  la  experiencia  de  nuestra  unidad,  en  cuanto  al  tratamiento  otorgado  y
su evolución  posquirúrgica,  de  los  pacientes  con  hemangiomas  hepáticos.
Material  y  métodos: Estudio  retrospectivo,  en  14  pacientes  con  diagnóstico  histopatológico  de
hemangioma  hepático.  Se  analizaron  variables  sociodemográﬁcas  y  relacionadas  con  el  tumour
y el  acto  quirúrgico,  así  como  las  complicaciones.
Resultados:  Se  analizaron  14  pacientes,  7  hombres  y  7  mujeres  con  una  edad  media  de
43.43 ±  15.03  an˜os;  el  taman˜o  promedio  de  los  hemangiomas  fue  de  6.86  ±  3.5  cm.  Ocho  (57.1%)
se encontraron  en  el  lóbulo  derecho,  3  (21.4%)  se  encontraron  en  el  lóbulo  izquierdo  y  3  (21.4%)
se encontraron  en  el  lóbulo  caudado.  Se  realizó  resección  en  7  pacientes  (50%),  enucleación  en
5 pacientes  (35.7%)  y  biopsia  en  2  pacientes  (14.3%).  No  se  encontró  relación  entre  la  patología,
el sexo  y  la  localización  del  tumour.  No  hubo  morbimortalidad.
Conclusiones:  Los  hemangiomas  hepáticos  en  nuestro  hospital  guardan  características  similares
a las  descritas  en  otros  estudios  y  el  tratamiento  quirúrgico  en  nuestro  hospital  ofrece  buenos
resultados.
© 2016  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/s/by-nc-nd/
4.0/).
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clinical  ﬁles  were  reviewed  and  the  following  variables
extracted:  age,  gender,  body  mass  index  (BMI),  size  andackground
iver  haemangiomas  are  the  most  common  benign  tumours,
ith  a  prevalence  of  0.4--7%  in  autopsies.  They  are  found
n  1--20%  of  the  population  in  general  and  their  incidence  of
iscovery  through  abdominal  ultrasound  performed  for  other
ndications  is  1.7%.  The  tumours  may  be  single  in  30--35%  or
ultiple  in  10--40%.1--6 The  majority  of  haemangiomas  are
mall  (under  1  cm  in  diameter)  and  are  considered  giant
hen  their  diameter  surpasses  4  cm,  which  represents  10%
f  them.  The  average  presentation  age  ranges  from  40
o  60  and  they  are  more  commonly  presented  in  women
woman:man  5:1).1,3,4,7,8
The  majority  of  liver  haemangiomas  are  asymptomatic,
specially  when  they  are  below  4  cm,  and  may  be  safely
reated  by  observation.2,4 The  predominant  symptom  is
bdominal  pain,  mainly  in  the  upper  right  quadrant.  They
ay  also  present  as  a  form  of  biliary  colic  pain,  with  obstruc-
ive  jaundice  and  gastric  obstruction.  Physical  examination
n  the  majority  of  cases  reports  normal,  except  in  some
ases  where  the  size  of  the  haemangioma  means  that  it
ecomes  a  palpable  mass.  Other  less  common  symptoms  are
hylous  ascites,  fever.  Kasabach  Merritt  syndrome  may  also
resent.3,4,8,9
At  present,  surgery  is  the  most  effective  therapy  for
eﬁnitive  treatment  of  liver  haemangiomas.  However,  opti-
al  management  for  patients  with  giant  haemangiomas
emains  controversial.3 Choosing  enucleation  over  formal
esection  depends  on  several  factors:  the  most  important
s  diagnostic  certainty  and  anatomical  considerations  such
s  the  location  and  extension  of  the  lesion.  Resection  may
l
se  preferred  for  the  potentially  malignant  tumours  and  for
umours  which  replace  a  liver  segment.3
Successful  treatment  of  giant  liver  haemangiomas,  as
reviously  mentioned,  depends  on  diagnostic  conﬁrmation
nd  when  the  tumour  does  require  surgery  to  determine
hich  type  of  surgery  is  required.  Other  indications  for
urgery  include:  uncertain  diagnosis,  growth  of  the  haeman-
ioma,  professions  where  the  person  may  suffer  trauma  of
he  abdomen,  dyspepsia,  persistent  thrombocytopenia  and
upture  with  intraperitoneal  haemorrhage.9,10
The  aim  of  this  study  was  to  determine  the  most  fre-
uent  type  of  surgery  administered  to  patients  with  liver
aemangiomas  and  assess  their  post  surgical  evolution  in  our
nit.
aterial and methods
 retrospective,  transversal,  analytical  study  was  conducted
hich  included  14  patients,  with  histopathologic  diagnosis
f  liver  haemangioma,  who  had  had  surgery  with  resection,
nucleation  or  had  undergone  biopsy  between  April  1,  2008
nd  30  April,  2015  in  the  Unidad  Médica  de  Alta  Espe-
ialidad,  Hospital  de  Especialidades  No.  14,  Centro  Médico
acional  Adolfo  Ruiz  Cortínez,  Instituto  Mexicano  del  Seguro
ocial  (Veracruz,  Mexico).  Prior  to  seeking  authorisation
rom  the  local  Ethics  and  Research  Committee  of  our  unit,ocation  of  haemangioma,  date  of  surgery,  referral  for
urgery,  type  of  surgery,  Pringle  manoeuvre,  blood  loss,
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number  of  blood  packs  transfused,  days  in  hospital,  oper-
ating  time  and  complications.  All  the  patients  were  studied
with  standard  ultrasound  and  contrast  computed  tomogra-
phy.  Patients  with  a  ﬁnal  diagnosis  which  was  different  to
liver  haemangioma  were  excluded  and  those  patients  who
had  an  incomplete  or  illegible  clinical  record  were  also
excluded.
Associations  or  signiﬁcant  differences  regarding  the
tumour  and  its  management  were  sought,  depending  on  the
gender,  in  addition  to  location  and  size.
Statistical  analysis
Statistical  analysis  of  continuous  and  discreet  variables
was  measured  in  averages,  standard  deviation  and  range.
Categorical  variables  were  measured  in  frequencies  and  per-
centages.  To  compare  continuous  and  discreet  variables  the
Student’s  t-test  or  Wilcoxon  analysis  was  used.
The  Chi  square  test  and  ANOVA  were  used  to  compare  cat-
egorical  variables.  p  <  0.05  was  considered  to  be  statistically
signiﬁcant.  SPSS  version  21  software  was  used  for  analysis.
Results
Of  the  14  patients,  7  were  men  (50%)  and  7  were  women
(50%).  The  mean  presentation  age  was  43.43  ±  15.03  years
(15--64),  mean  weight  was  70.94  ±  13.37  kg  (52--98),  aver-
age  BMI  was  26.64  ±  4.61  kg/m2 (21.8--39),  average  size  of
haemangiomas  was  6.86  ±  3.5  cm  (2--15),  2  of  them  (14.28%)
were  under  4  cm.  Eight  (57.1%)  were  found  in  the  right  lobe,
3  (21.4%)  were  found  in  the  left  lobe  and  3  (21.4%)  were
found  in  the  caudate  lobe.  Preoperative  laboratory  values
are  shown  in  Table  1.
The  most  frequently  used  type  of  surgery  was  resection,
for  a  total  of  7  patients  (50%),  followed  by  enucleation  for  5
patients  (35.7%)  and  lastly  biopsy  in  2  patients  (14.3%).  Biop-
sies  were  only  carried  out  on  the  caudate  lobe.  The  primary
indication  for  surgery  was  pain  (57.1%),  followed  by  doubtful
diagnosis  (28.6%)  and  dysphagia  (14.3%).  The  average  time
in  surgery  was  174.38  ±  41.09  min  (105--240),  with  a  mean
hospital  stay  of  5.36  ±  2.6  days  (2--10),  average  blood  loss
of  517.86  ±  533.35  ml  (100--2150)  with  a  mean  transfusion  of
0.57  ±  1.01  blood  packs  (0--3).  The  Pringle  manoeuvre  was
performed  in  5  cases  (35.7%).  There  were  no  complications
Table  1  Pre-surgical  laboratory  results  of  patients  treated
with surgery  for  liver  haemangioma.
Parameter  Laboratory  value  found
Haemoglobin,  mg/dl  13.77  ±  1.16  (11.9--15.4)
Haematocrit,  %  41.87  ±  2.92  (36.8--45.6)
Glucose,  mg/dl  91  ±  9.8  (75--104)
Urea, mg/dl  27.93  ±  6.82  (17--40.7)
Creatinine,  mg/dl  0.93  ±  0.14  (0.7--1.2)
Ureic  nitrogen  in  blood,  mg/dl  13.87  ±  2.78  (9--19)
Total  bilirubin,  mg/dl  0.6  ±  0.28  (0.26--1.22)
Indirect  bilirubin,  mg/dl  0.38  ±  0.19  (0.1--0.7)
Direct  bilirubin,  mg/dl 0.21  ±  0.16  (0.09--0.6)
Total  proteins,  mg/dl 7.09  ±  0.76  (6--8.5)
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l  in  south-east  Mexico  3
elated  to  surgery  in  any  of  the  patients  included  in  the
tudy,  nor  were  there  any  perioperative  deaths.
Patients  with  haemangioma  located  in  the  right  hepatic
obe  had  signiﬁcantly  lower  levels  of  blood  urea  nitrogen
12.32  ±  2.09  mg/dl)  than  those  where  it  was  located  in
he  left  lobe  (17.20  ±  1.55  mg/dl)  (p  =  0.01).  Patients  with
aemangiomas  located  in  the  right  lobe  presented  with  sig-
iﬁcantly  lower  levels  of  total  bilirubin  (0.50  ±  0.18  mg/dl)
ompared  with  those  where  it  was  located  in  the  left  lobe
0.95  ±  0.25  mg/dl)  (p  =  0.03).  Patients  with  haemangioma
ocated  in  the  caudate  lobe  presented  with  signiﬁcantly
ower  levels  of  indirect  bilirubin  (0.23  ±  0.5  mg/dl)  than
hose  where  it  was  found  in  the  left  lobe  (0.64  ±  0.04  mg/dl)
p  =  0.009).  No  signiﬁcant  difference  was  found  regarding
ender  or  tumour  location,  size,  type  of  surgery,  time
n  surgery,  perioperative  bleeding,  hospital  stay  duration,
umber  of  blood  packs  transfused  or  use  of  the  Pringle
anoeuvre.
iscussion
he  ﬁndings  from  our  study  indicate  that  the  presentation
f  liver  haemangiomas  in  our  hospital  is  similar  to  that
escribed  with  regards  to  socio-demographic  factors  and
umour  characteristics.  Our  ﬁndings  indicate  that  surgical
reatment  has  a  satisfactory  outcome  in  any  of  its  modali-
ies.
Similar  results  to  that  published  with  regard  to  presen-
ation  age  were  found.  However,  in  our  study  no  preference
owards  any  gender  was  discovered,  which  differs  from  that
eported  by  Lerner  et  al.2 with  an  88%  predomination  of
omen,  and  by  the  Asian  series,5 where  the  frequency  of
resentation  in  women  is  73.8%.  Location  of  the  tumour  was
rimarily  in  the  right  hepatic  lobe,  similar  to  that  published
n  the  Western  and  Mexican  series2,9 and  different  from  the
riental  series5 who  reported  a  greater  frequency  in  the  left
epatic  lobe.  Regarding  haemangioma  size,  in  our  study  the
ean  was  lower  than  in  other  series.2,5--7,10,11
The  most  frequently  reported  referral  for  surgery  in  our
eries  was  for  abdominal  pain,  similarly  to  that  reported  in
ther  series.1,6,11--13 The  patients  who  underwent  surgery  on
uspected  diagnosis  were  referred  from  other  hospitals  and
heir  imaging  studies  with  inconclusive  radiologic  diagnoses,
ere  produced  outside  our  unit.  We  therefore  chose  to  offer
urgical  treatment  to  the  patient.  The  type  of  surgical  inter-
ention  most  frequently  performed  was  resection,  similar  to
hat  published  by  Singh  et  al.10 However,  they  favoured  enu-
leation  as  the  procedure  of  choice.  Ozden  et  al.11 reported
reater  frequency  of  enucleation  and  they  are  in  favour  of
erforming  it,  since  they  consider  it  a  fast  and  safe  pro-
edure.  In  our  ﬁndings  we  found  no  signiﬁcant  differences
ith  regards  to  the  type  of  surgery  performed,  similar  to
hat  reported  by  the  Italian  series.13
In  our  series  there  was  less  blood  loss  and  surgery  time
as  lower  compared  with  others,5,6,9 because  the  size  of
he  haemangiomas  was  smaller,  and  the  number  of  reported
ases  were  fewer  than  in  other  studies,  taking  into  account
hat  they  include  2  biopsies.  Hospital  stay  in  our  series  was
imilar  to  that  published  by  Singh  et  al.10 who  in  his  group  of
nucleations  presented  a  mean  of  5.6  days  and  lower  than
he  ﬁgure  of  their  group  of  resections  with  a  mean  of  10  days.
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Table  2  Comparison  of  the  characteristics  of  patients  and  of  the  surgical  treatment  with  other  series  published  in  Mexico.
Ortiz  et  al.
n =  14
Martínez  González
et  al.6
n  =  24
Moctezuma
Velázquez  et  al.9
n  =  9
Study  time  period  (years)  April  2008--April
2015  (7)
August  1995--May
2003  (8)
January
1990--Novemer
2008  (11)
Mean age  (years)  45.6  43.6  46.7
Mean size  (cm)  6.77  8.5  4.4
Median surgery  time  (range)  180  (145--240)  192  (60--330)  600  (120--640)
Surgical indication  (%) AP  (61.5)
DD (30.8)
AP  (83.3)
DD  (12.5)
AP  (33.0)
DD  (12.5)
Surgical mortality  (%) 0  (0) 0  (0) 0  (0)
Pringle manoeuvre  (%)  37.50  100  NR
Type of  surgery  (%)  Enucleation
(35.7),  resection
(50),  biopsy  (14.3)
Enucleation
(33.3),  resection
(66.6),  biopsy
(0.0)
Enucleation  (11)
resection  (67)
biopsy  (22)
Preoperative  haemoglobin  in  g/dl,
median  (range)
13.8  (11.9--15.4)  NR  14.2  (12--17)
Transoperative  bleeding,  ml  (range)  550  (150--2150)  1000  (100--4000)  500  (105--8000)
Globular packs  transfused,  mean  (range)  0.57  (0--3)  NR  2.5  (1--9)
Mean hospital  stay  in  days  (range)  5.36  (2--10)  7.4  (3--25)  NR
Complications  n  (%)  0  (0)  4  (16.6)  3  (33)
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RAP: abdominal pain; DD: doubtful diagnosis; NR: not reported.
ospital  stay  duration  in  our  study  was  lower  since  transop-
rative  haemorrhage  was  comparatively  lower,  as  was  the
umber  of  cases.  There  were  no  complications  or  mortality
n  our  series,  unlike  those  of  other  authors,  who  reported
orbidities  from  13.1%  to  41.6%.1,2,5,9,10
Few  Mexican  studies  describe  the  natural  history  and
reatment  of  liver  haemangiomas  in  Mexico,  and  most  are
eport  cases.
In  2003  Martínez  González6 resected/enucleated  24
aemangiomas  (22  cavernous  haemangiomas  and  2  haeman-
iomatoses)  in  2  hospitals,  mainly  in  women,  with  a  91.6%
esolution  of  symptoms.  Another  Mexican  series  of  patients
ith  liver  haemangioma  corresponded  to  that  published  by
octezuma  Velázquez  in  2014,9 in  which  during  a  period  of
8  years,  57  patients  with  liver  haemangiomas  were  studied
n  a  follow-up  period  of  66  months.  56.14%  of  them  cor-
esponded  to  giant  liver  haemangiomas.  Ten  patients  were
symptomatic  and  only  9  patients  underwent  surgery  and  2
ere  treated  with  biopsy,  without  there  being  any  incidence
f  perioperative  morality.
Table  2  compares  our  results  with  those  of  the  series
ublished  in  Mexico.  Unlike  the  results  published  by  other
uthors,6,9 we  only  include  patients  who  underwent  surgery,
ince  we  only  receive  inter-consultancy  patients  when  there
s  a  referral  for  surgery.  It  is  of  note  that  the  mean  hospital
tay  in  our  patients  is  lower,  with  no  complications,  although
umour  size  is  also  smaller.
Our  study  has  several  limitations.  It  is  a  retrospective
tudy,  with  a  limited  sample  size  and  we  include  2  patients
n  this  study  upon  whom  biopsy  was  performed.  However,
ur  surgical  outcomes  reﬂecting  surgery  time  and  no  morbid-
ty  or  mortality  are  an  improvement  upon  those  previously
ublished  in  Mexican  literature.onclusions
iver  haemangiomas  in  our  hospital  have  similar  char-
cteristics  to  those  described  in  other  studies  and  the
urgical  treatment  in  our  hospital  offers  good  outcomes.  The
atients  with  liver  haemangioma  surpassing  4  cm  with  symp-
oms  are  referred  for  surgery  (resection  or  enucleation).
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